STIFEL FINANCIAL CORP - DIPLOMAT PHARMACY INC ownership

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q2 2018$1,449,000
-15.0%
56,696
-33.0%
0.00%
-20.0%
Q1 2018$1,705,000
+26.8%
84,669
+25.7%
0.01%
+25.0%
Q4 2017$1,345,000
+214.3%
67,376
+342.1%
0.00%
+100.0%
Q3 2016$428,00015,2390.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q3 2023
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 445,200$7,101,0001.80%
Redmile Group, LLC 1,254,342$20,007,0001.30%
Irving Magee Investment Management 166,505$2,656,0001.02%
BROADVIEW ADVISORS LLC 376,050$5,998,0000.83%
Sivik Global Healthcare LLC 101,000$1,611,0000.75%
FRONTIER CAPITAL MANAGEMENT CO LLC 5,455,461$87,015,0000.64%
Iguana Healthcare Management, LLC 75,000$1,196,0000.59%
RIVERBRIDGE PARTNERS LLC 1,464,286$23,355,0000.47%
HERMES INVESTMENT MANAGEMENT LTD 1,772,777$28,276,0000.46%
Endurant Capital Management LP 85,043$1,356,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders